Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1111JC101----1件: 25 💬
289 Zr-Df-crefmirlimab1件: Crefmirlimab---2件: 13, 25 💬
3Application of T-lymphocytes----1件: 25 💬
4Brincidofovir1件: Brincidofovir1件: Brincidofovir 💬 --1件: 25 💬
5CE-VST01-JC1件: CE-VST01-JC---1件: 25 💬
6Cidofovir1件: Cidofovir1件: Cidofovir 💬 --1件: 25 💬
7Collection of blood and urine----1件: 25 💬
8Crefmirlimab1件: Crefmirlimab---4件: 13, 25, 51, 53 💬
9CYT107----1件: 25 💬
10Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--8件: 11, 13, 14, 25, 34, 49, 60, 65 💬
11Diagnostic Test: Brain MRI----2件: 25, 229 💬
12Didanosine1件: Didanosine1件: Didanosine 💬 --2件: 25, 265 💬
13Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬 --5件: 13, 25, 93, 265, 325 💬
14Enfuvirtide1件: Enfuvirtide1件: Enfuvirtide 💬 --2件: 25, 265 💬
15Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬30件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
16Immune Checkpoint Inhibitors----3件: 25, 51, 53 💬
17Interferon alfa1件: Interferon alfa1件: Interferon alfa 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬5件: 25, 26, 28, 56, 96 💬
18Interferon alfa-2b2件: Interferon alfa,
Interferon alfa-2b		2件: Interferon alfa-2b ,
Interferon alfa 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 25, 26 💬
19Interleukin-71件: Interleukin-7---1件: 25 💬
20Lariam----1件: 25 💬
21MEFLOQUINE1件: Mefloquine2件: Mefloquine hydrochloride ,
Mefloquine 💬 		--2件: 25, 46 💬
22Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
23NATALIZUMAB1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 17件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
24Neurological evaluation----1件: 25 💬
25NT-I7----1件: 25 💬
26Pembrolizumab1件: Pembrolizumab1件: Pembrolizumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬3件: 25, 97, 285 💬
27Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection1件: Pembrolizumab1件: Pembrolizumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬1件: 25 💬
28PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
29Probenecid1件: Probenecid1件: Probenecid 💬 --1件: 25 💬
30PyVST----1件: 25 💬
31Recombinant human interleukin-71件: Interleukin-7---1件: 25 💬
32Spinal tap----1件: 25 💬
33Tenofovir1件: Tenofovir1件: Tenofovir 💬 --8件: 2, 6, 13, 25, 26, 93, 265, 325 💬
34Tenofovir-Emtricitabine2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬 		--1件: 25 💬
35TERIFLUNOMIDE1件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬4件: 13, 25, 26, 63 💬
36Topotecan1件: Topotecan2件: Topotecan hydrochloride ,
Topotecan 💬 		--1件: 25 💬
37TYSABRI----3件: 13, 25, 63 💬
38Zalcitabine1件: Zalcitabine1件: Zalcitabine 💬 --1件: 25 💬
39Zidovudine1件: Zidovudine1件: Zidovudine 💬 --6件: 25, 26, 135, 265, 325, 331 💬